5754-2992 Screening compound: N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-3,4-dihydrophthalazin-1-yl}phenyl]propanamide

5754-2992 Screening compound: N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-3,4-dihydrophthalazin-1-yl}phenyl]propanamide
5754-2992 Screening compound: N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-3,4-dihydrophthalazin-1-yl}phenyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 5754-2992
N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-3,4-dihydrophthalazin-1-yl}phenyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5754-2992

Molecular Formula

C28H33N5O4 (C28 H33 N5 O4)

Compound Name

N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-3,4-dihydrophthalazin-1-yl}phenyl]propanamide

IUPAC name

N-[2-(morpholin-4-yl)-5-{4-oxo-3-[2-oxo-2-(piperidin-1-yl)ethyl]-34-dihydrophthalazin-1-yl}phenyl]propanamide

SMILES

CCC(Nc(cc(cc1)C(c2c3cccc2)=NN(CC(N2CCCCC2)=O)C3=O)c1N1CCOCC1)=O

InChI

InChI=1S/C28H33N5O4/c1-2-25(34)29-23-18-20(10-11-24(23)31-14-16-37-17-15-31)27-21-8-4-5-9-22(21)28(36)33(30-27)19-26(35)32-12-6-3-7-13-32/h4-5,8-11,18H,2-3,6-7,12-17,19H2,1H3,(H,29,34)

InChI Key

WHDFSDCIHWVRKL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03995324

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.378

Distribution Coefficient, logD

2.378

Water Solubility, LogSw

-3.24

Polar Surface Area

77.099

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

0.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

5754-2992 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 5754-2992 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5754-2992?
Check Price and Availability of 5754-2992, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5754-2992 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5754-2992
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5754-2992
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5754-2992 available by request